Founded with a mission to improve the quality of life for individuals suffering from stress urinary incontinence (SUI), UroMedica, Inc. is a global medical device company. The company specializes in developing and marketing adjustable balloon devices designed to treat SUI in both men and women. Their primary products, ACT® (Adjustable Continence Therapy) for women and ProACT™ for men, offer minimally invasive, adjustable treatment options aimed at helping patients reclaim their continence and enhance their daily lives.
UroMedica has garnered attention for its innovative approach to treating SUI, with its products being used worldwide. The company’s notable achievements include the successful development and commercialization of ACT® and ProACT™, which have provided effective solutions for many patients. UroMedica's impact is significant in the medical community, offering new hope and improved outcomes for those affected by urinary incontinence.
